Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Landowski, B. Vig, Xueqin Song, G. Amidon (2005)
Targeted delivery to PEPT1-overexpressing cells: Acidic, basic, and secondary floxuridine amino acid ester prodrugsMolecular Cancer Therapeutics, 4
Friederike Meyer-Wentrup, Ullrich Karbach, V. Gorboulev, P. Arndt, Hermann Koepsell (1998)
Membrane localization of the electrogenic cation transporter rOCT1 in rat liver.Biochemical and biophysical research communications, 248 3
I. Knütter, B. Hartrodt, S. Theis, M. Foltz, M. Rastetter, H. Daniel, K. Neubert, M. Brandsch (2004)
Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 21 1
Michael Bolger, Ian Haworth, Aaron Yeung, David Ann, H. Grafenstein, S. Hamm-Alvarez, Curtis Okamoto, Kwang-Jin Kim, Sujit Basu, Sharon Wu, Vincent Lee (1998)
Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1.Journal of pharmaceutical sciences, 87 11
A. Rizwan, W. Krick, G. Burckhardt (2007)
The Chloride Dependence of the Human Organic Anion Transporter 1 (hOAT1) Is Blunted by Mutation of a Single Amino Acid*Journal of Biological Chemistry, 282
M. Ganapathy, Wei Huang, Hong Wang, V. Ganapathy, F. Leibach (1998)
Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.Biochemical and biophysical research communications, 246 2
N. Kimura, S. Masuda, Y. Tanihara, Harumasa Ueo, M. Okuda, T. Katsura, K. Inui (2005)
Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.Drug metabolism and pharmacokinetics, 20 5
S. Patil, L. Ngo, J. Unadkat (2000)
Structure-inhibitory profiles of nucleosides for the human intestinal N1 and N2 Na+-nucleoside transportersCancer Chemotherapy and Pharmacology, 46
C. Landowski, Xueqin Song, P. Lorenzi, J. Hilfinger, G. Amidon (2005)
Floxuridine Amino Acid Ester Prodrugs: Enhancing Caco-2 Permeability and Resistance to Glycosidic Bond MetabolismPharmaceutical Research, 22
K. Barnes, H. Dobrzynski, S. Foppolo, P. Beal, F. Ismat, Elspeth Scullion, Lijie Sun, J. Tellez, M. Ritzel, W. Claycomb, C. Cass, J. Young, R. Billeter-Clark, M. Boyett, S. Baldwin (2006)
Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pHCirculation Research, 99
S. Cha, T. Sekine, Jun-ichi Fukushima, Y. Kanai, Yukari Kobayashi, T. Goya, H. Endou (2001)
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.Molecular pharmacology, 59 5
S. Marcé, M. Molina-Arcas, N. Villamor, F. Casado, E. Campo, M. Pastor-Anglada, D. Colomer (2006)
Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.Haematologica, 91 7
M. Takeda, Suparat Khamdang, S. Narikawa, Hiroaki Kimura, M. Hosoyamada, S. Cha, T. Sekine, H. Endou (2002)
Characterization of Methotrexate Transport and Its Drug Interactions with Human Organic Anion TransportersJournal of Pharmacology and Experimental Therapeutics, 302
Vickers (2004)
Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiaeNucleos Nucleot Nucleic Acids, 23
Jing Zhang, Tracey Tackaberry, M. Ritzel, Taylor Raborn, Gerry Barron, S. Baldwin, J. Young, C. Cass (2006)
Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3.The Biochemical journal, 394 Pt 2
Rong Chen, J. Nelson (2000)
Role of organic cation transporters in the renal secretion of nucleosides.Biochemical pharmacology, 60 2
K. Ullrich (1997)
Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for SubstratesThe Journal of Membrane Biology, 158
Frank Doring, D. Dorn, Ulla Bachfischer, Salah Amasheh, M. Herget, Hannelore Daniel (1996)
Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms.The Journal of Physiology, 497
Ming Hu, Lixing Zheng, Jiyue Chen, Lijuan Liu, Yanping Zhu, A. Dantzig, R. Stratford (2004)
Mechanisms of Transport of Quinapril in Caco-2 Cell Monolayers: Comparison with CephalexinPharmaceutical Research, 12
Hong Shen, David Smith, Tianxin Yang, Yuning Huang, J. Schnermann, F. Brosius (1999)
Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney.American journal of physiology. Renal physiology, 276 5
M. Griffiths, S. Yao, F. Abidi, S. Phillips, C. Cass, J. Young, S. Baldwin (1997)
Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.The Biochemical journal, 328 ( Pt 3)
M. Brandsch, I. Knütter, E. Bosse-Doenecke (2008)
Pharmaceutical and pharmacological importance of peptide transportersJournal of Pharmacy and Pharmacology, 60
D. Groneberg, F. Döring, S. Theis, M. Nickolaus, A. Fischer, H. Daniel (2002)
Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein.American journal of physiology. Endocrinology and metabolism, 282 5
M. Sundaram, S. Yao, J. Ingram, Zoe Berry, F. Abidi, C. Cass, S. Baldwin, J. Young (2001)
Topology of a Human Equilibrative, Nitrobenzylthioinosine (NBMPR)-sensitive Nucleoside Transporter (hENT1) Implicated in the Cellular Uptake of Adenosine and Anti-cancer Drugs*The Journal of Biological Chemistry, 276
Derek Bone, Kevin Robillard, M. Stolk, J. Hammond (2007)
Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2Molecular Membrane Biology, 24
M. Griffiths, N. Beaumont, S. Yao, M. Sundaram, C. Boumah, A. Davies, F. Kwong, I. Coe, C. Cass, J. Young, S. Baldwin (1997)
Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugsNature Medicine, 3
Perry (2007)
Substrate specificity in a model of the human organic anion transporter 3J Fed Am Soc Exp Biol, 21
J. Gray, R. Owen, K. Giacomini (2004)
The concentrative nucleoside transporter family, SLC28Pflügers Archiv, 447
S. Baldwin, S. Yao, R. Hyde, A. Ng, S. Foppolo, K. Barnes, M. Ritzel, C. Cass, J. Young (2005)
Functional Characterization of Novel Human and Mouse Equilibrative Nucleoside Transporters (hENT3 and mENT3) Located in Intracellular Membranes*Journal of Biological Chemistry, 280
I. Knütter, I. Rubio-Aliaga, M. Boll, G. Hause, H. Daniel, K. Neubert, M. Brandsch (2002)
H+-peptide cotransport in the human bile duct epithelium cell line SK-ChA-1.American journal of physiology. Gastrointestinal and liver physiology, 283 1
Frank Visser, Lijie Sun, V. Damaraju, Tracey Tackaberry, Yunshan Peng, M. Robins, S. Baldwin, J. Young, C. Cass (2007)
Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover*Journal of Biological Chemistry, 282
J. Mata, J. Garcia-Manteiga, M. Lostao, S. Fernández-Veledo, E. Guillén-Gómez, I. Larráyoz, J. Lloberas, F. Casado, M. Pastor-Anglada (2001)
Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug.Molecular pharmacology, 59 6
M. Molina-Arcas, B. Bellosillo, F. Casado, E. Montserrat, J. Gil, D. Colomer, M. Pastor-Anglada (2003)
Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia.Blood, 101 6
E. Cheon, J. Hong, Hyo-Kyung Han (2006)
Enhanced cellular uptake of Ara‐C via a peptidomimetic prodrug, L‐valyl‐ara‐C in Caco‐2 cellsJournal of Pharmacy and Pharmacology, 58
A. Kulkarni, I. Haworth, T. Uchiyama, V. Lee (2003)
Analysis of Transmembrane Segment 7 of the Dipeptide Transporter hPepT1 by Cysteine-scanning Mutagenesis*Journal of Biological Chemistry, 278
Jason Chen, Zhishan Li, H. Pan, D. Murphy, H. Tamir, H. Koepsell, M. Gershon (2001)
Maintenance of Serotonin in the Intestinal Mucosa and Ganglia of Mice that Lack the High-Affinity Serotonin Transporter: Abnormal Intestinal Motility and the Expression of Cation TransportersThe Journal of Neuroscience, 21
D. Gründemann, B. Schechinger, G. Rappold, E. Schömig (1998)
Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporterNature Neuroscience, 1
I. Rubio-Aliaga, Hannelore Daniel (2008)
Peptide transporters and their roles in physiological processes and drug dispositionXenobiotica, 38
K. Bleasby, Laura Hall, J. Perry, H. Mohrenweiser, J. Pritchard (2005)
Functional Consequences of Single Nucleotide Polymorphisms in the Human Organic Anion Transporter hOAT1 (SLC22A6)Journal of Pharmacology and Experimental Therapeutics, 314
H. Koepsell, B. Schmitt, V. Gorboulev (2003)
Organic cation transporters.Reviews of physiology, biochemistry and pharmacology, 150
Y. Uwai, Hiroki Ida, Y. Tsuji, T. Katsura, K. Inui (2007)
Renal Transport of Adefovir, Cidofovir, and Tenofovir by SLC22A Family Members (hOAT1, hOAT3, and hOCT2)Pharmaceutical Research, 24
S. Yao, A. Ng, Melissa Slugoski, Kyla Smith, Ras Mulinta, E. Karpinski, C. Cass, S. Baldwin, J. Young (2007)
Conserved Glutamate Residues Are Critically Involved in Na+/Nucleoside Cotransport by Human Concentrative Nucleoside Transporter 1 (hCNT1)*Journal of Biological Chemistry, 282
William Sun, R. Wu, P. Poelje, M. Erion (2001)
Isolation of a family of organic anion transporters from human liver and kidney.Biochemical and biophysical research communications, 283 2
(2006)
A three-dimensional model of human organic anion transporter 1: Aromatic amino acids required for substrate transport
R. Moaddel, S. Patel, K. Jóźwiak, R. Yamaguchi, P. Ho, I. Wainer (2005)
Enantioselective binding to the human organic cation transporter-1 (hOCT1) determined using an immobilized hOCT1 liquid chromatographic stationary phase.Chirality, 17 8
Shuzhong Zhang, Katherine Lovejoy, James Shima, Leah Lagpacan, Y. Shu, A. Lapuk, Ying Chen, T. Komori, J. Gray, Xin Chen, S. Lippard, K. Giacomini (2006)
Organic cation transporters are determinants of oxaliplatin cytotoxicity.Cancer research, 66 17
Mei Hong, Fanfan Zhou, Kevin Lee, G. You (2007)
The Putative Transmembrane Segment 7 of Human Organic Anion Transporter hOAT1 Dictates Transporter Substrate Binding and StabilityJournal of Pharmacology and Experimental Therapeutics, 320
Melissa Slugoski, Shauna Loewen, A. Ng, Kyla Smith, S. Yao, E. Karpinski, C. Cass, S. Baldwin, J. Young (2007)
Specific mutations in transmembrane helix 8 of human concentrative Na+/nucleoside cotransporter hCNT1 affect permeant selectivity and cation coupling.Biochemistry, 46 6
Thack Lang, J. Young, C. Cass (2004)
Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.Molecular pharmacology, 65 4
Suparat Khamdang, M. Takeda, Rie Noshiro, S. Narikawa, A. Enomoto, N. Anzai, P. Piyachaturawat, H. Endou (2002)
Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory DrugsJournal of Pharmacology and Experimental Therapeutics, 303
H. Krishnamurthy, C. Piscitelli, E. Gouaux (2009)
Unlocking the molecular secrets of sodium-coupled transportersNature, 459
M. Clarke, V. Damaraju, Jing Zhang, D. Mowles, Tracey Tackaberry, Thach Lang, Kyla Smith, J. Young, B. Tomkinson, C. Cass (2006)
The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.Molecular pharmacology, 70 1
L. Mangravite, J. Lipschutz, K. Mostov, K. Giacomini (2001)
Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line.American journal of physiology. Renal physiology, 280 5
H. Daniel, Britta Spanier, G. Kottra, D. Weitz (2006)
From bacteria to man: archaic proton-dependent peptide transporters at work.Physiology, 21
S. Jarvis, J. Thorn, P. Glue (1998)
Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine‐sensitive (es)‐nucleoside transportersBritish Journal of Pharmacology, 123
J. Farrell, H. Elsaleh, M. García, R. Lai, A. Ammar, W. Regine, R. Abrams, A. Benson, J. Macdonald, C. Cass, A. Dicker, J. Mackey (2009)
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.Gastroenterology, 136 1
S. Hamilton, S. Yao, J. Ingram, D. Hadden, M. Ritzel, M. Gallagher, P. Henderson, C. Cass, J. Young, S. Baldwin (2001)
Subcellular Distribution and Membrane Topology of the Mammalian Concentrative Na+-Nucleoside Cotransporter rCNT1*The Journal of Biological Chemistry, 276
(2002)
Functional and Molecular Characterization of Nucleobase Transport by Recombinant Human and Rat Equilibrative Nucleoside Transporters 1 and 2 CHIMERIC CONSTRUCTS REVEAL A ROLE FOR THE ENT2 HELIX 5–6 REGION IN NUCLEOBASE TRANSLOCATION*
A. Kulkarni, D. Davies, J. Links, L. Patel, V. Lee, I. Haworth (2006)
A Charge Pair Interaction Between Arg282 in Transmembrane Segment 7 and Asp341 in Transmembrane Segment 8 of hPepT1Pharmaceutical Research, 24
A. Fotoohi, M. Lindqvist, C. Peterson, F. Albertioni (2006)
Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.Biochemical and biophysical research communications, 343 1
R. Moaddel, R. Yamaguchi, P. Ho, S. Patel, C.P.S. Hsu, V. Subrahmanyam, I. Wainer (2005)
Development and characterization of an immobilized human organic cation transporter based liquid chromatographic stationary phase.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 818 2
S. Yao, S. Yao, M. Sundaram, M. Sundaram, Eugene Chomey, Eugene Chomey, C. Cass, C. Cass, S. Baldwin, S. Baldwin, J. Young, J. Young (2001)
Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2.The Biochemical journal, 353 Pt 2
J. Mackey, L. Jennings, M. Clarke, Cheryl Santos, L. Dabbagh, Michaela Všianská, S. Koski, R. Coupland, S. Baldwin, J. Young, C. Cass (2002)
Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 1
A. Kulkarni, I. Haworth, V. Lee (2003)
Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway.Biochemical and biophysical research communications, 306 1
Rajgopal Govindarajan, G. Leung, Mingyan Zhou, C. Tse, Joanne Wang, J. Unadkat (2009)
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.American journal of physiology. Gastrointestinal and liver physiology, 296 4
S. Verhaagh, Norbert Schweifer, Denise Barlow, Ronald Zwart (1999)
Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27.Genomics, 55 2
Y. Fei, Jin-Cai Liu, Takuya Fujita, Rong Liang, Vadivel Ganapathy, F. Leibach (1998)
Identification of a potential substrate binding domain in the mammalian peptide transporters PEPT1 and PEPT2 using PEPT1-PEPT2 and PEPT2-PEPT1 chimeras.Biochemical and biophysical research communications, 246 1
M. Sundaram, S. Yao, A. Ng, M. Griffiths, C. Cass, S. Baldwin, J. Young (1998)
Chimeric Constructs between Human and Rat Equilibrative Nucleoside Transporters (hENT1 and rENT1) Reveal hENT1 Structural Domains Interacting with Coronary Vasoactive Drugs*The Journal of Biological Chemistry, 273
J. Perry, Chutima Srimaroeng, N. Dembla-Rajpal, Laura Hall, J. Pritchard (2007)
Substrate Specificity in a Model of the Human Organic Anion Transporter 3The FASEB Journal, 21
Sharon Wu, D. Ann, Kwang-Jin Kim, V. Lee (2005)
Fine tuning of rabbit equilibrative nucleoside transporter activity by an alternatively spliced variantJournal of Drug Targeting, 13
H. Daniel, G. Kottra (2004)
The proton oligopeptide cotransporter family SLC15 in physiology and pharmacologyPflügers Archiv, 447
Edmund Ho, Deborah Lin, D. Mendel, T. Cihlář (2000)
Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1.Journal of the American Society of Nephrology : JASN, 11 3
Hyo-Kyung Han, R. Vrueh, J. Rhie, K. Covitz, Philip Smith, Chao-pin Lee, D. Oh, W. Sadee, Gordon Amidon1 (1998)
5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide TransporterPharmaceutical Research, 15
J. Ward, Azeem Sherali, Z. Mo, C. Tse (2000)
Kinetic and Pharmacological Properties of Cloned Human Equilibrative Nucleoside Transporters, ENT1 and ENT2, Stably Expressed in Nucleoside Transporter-deficient PK15 CellsThe Journal of Biological Chemistry, 275
Kyoko Sawada, T. Terada, H. Saito, Y. Hashimoto, K. Inui (1999)
Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2British Journal of Pharmacology, 128
J. Jacobsson, T. Haitina, J. Lindblom, R. Fredriksson (2007)
Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family.Genomics, 90 5
Thack Lang, M. Selner, James Young, C. Cass (2001)
Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.Molecular pharmacology, 60 5
G. Kaler, David Truong, Akash Khandelwal, Megha Nagle, S. Eraly, P. Swaan, S. Nigam (2007)
Structural Variation Governs Substrate Specificity for Organic Anion Transporter (OAT) HomologsJournal of Biological Chemistry, 282
Wendy Suhre, S. Ekins, Cheng Chang, P. Swaan, S. Wright (2005)
Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2Molecular Pharmacology, 67
H. Motohashi, Yuji Sakurai, H. Saito, Satohiro Masuda, Y. Urakami, Maki Goto, Atsushi Fukatsu, Osamu Ogawa, K. Inui (2002)
Gene expression levels and immunolocalization of organic ion transporters in the human kidney.Journal of the American Society of Nephrology : JASN, 13 4
Vickers (1999)
Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q)Biochem J, 339
G. Burckhardt, N. Wolff (2000)
Structure of renal organic anion and cation transporters.American journal of physiology. Renal physiology, 278 6
Y. Fei, Wei Liu, P. Prasad, R. Kekuda, T. Oblak, Vadivel Ganapathy, F. Leibach (1997)
Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.Biochemistry, 36 2
M. Clarke, V. Damaraju, Jing Zhang, D. Mowles, Tracey Tackaberry, Thach Lang, Kyla Smith, J. Young, B. Tomkinson, C. Cass (2006)
The Role of Human Nucleoside Transporters in Cellular Uptake of 4′-Thio-β-d-arabinofuranosylcytosine and β-d-ArabinosylcytosineMolecular Pharmacology, 70
Yao (2001)
Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2Biochem J, 353
Astorga (2007)
Molecular basis for the differential sensitivity of OCT2 and OAT1 toward Hg2+J Fed Am Soc Exp Biol, 21
D. Groneberg, M. Nickolaus, J. Springer, Frank Döring, Hannelore Daniel, Axel Fischer, Axel Fischer (2001)
Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake.The American journal of pathology, 158 2
M. Handa, D. Choi, Ryan Caldeiro, R. Messing, A. Gordon, I. Diamond (2001)
Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site.Gene, 262 1-2
He obtained his B.Sc. degree in Chemistry at the University of Granada and a Ph.D. in Biomedicine from the University of Barcelona in 2008, under the supervision of Professor Marc -al Pastor-Anglada
C. Volk, V. Gorboulev, T. Budiman, G. Nagel, H. Koepsell (2003)
Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2.Molecular pharmacology, 64 5
M. Takeda, E. Babu, S. Narikawa, H. Endou (2002)
Interaction of human organic anion transporters with various cephalosporin antibiotics.European journal of pharmacology, 438 3
Yu K
Interaction of Human Organic Anion Transporters 2 and 4 with Organic Anion Transport Inhibitors Experimental Procedures
T. Uchiyama, A. Kulkarni, D. Davies, V. Lee (2003)
Biophysical Evidence for His57 as a Proton-Binding Site in the Mammalian Intestinal Transporter hPepT1Pharmaceutical Research, 20
T. Terada, Kyoko Sawada, H. Saito, Y. Hashimoto, K. Inui (2000)
Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2.European journal of pharmacology, 392 1-2
H. Ogihara, H. Saito, Bo-Chul Shin, T. Terada, Seiichi Takenoshita, Yukio Nagamachi, K. Inui, Kuniaki Takata (1996)
Immuno-localization of H+/peptide cotransporter in rat digestive tract.Biochemical and biophysical research communications, 220 3
Cheng Chang, P. Swaan, L. Ngo, P. Lum, S. Patil, J. Unadkat (2004)
Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.Molecular pharmacology, 65 3
Y. Shu, Y. Shu, C. Brown, R. Castro, RJ Shi, Emil Lin, R. Owen, SA Sheardown, L. Yue, E. Burchard, C. Brett, K. Giacomini (2008)
Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsClinical Pharmacology & Therapeutics, 83
Kyla Smith, Melissa Slugoski, Shauna Loewen, A. Ng, S. Yao, Xing-Zhen Chen, E. Karpinski, C. Cass, S. Baldwin, J. Young (2005)
The Broadly Selective Human Na+/Nucleoside Cotransporter (hCNT3) Exhibits Novel Cation-coupled Nucleoside Transport Characteristics*Journal of Biological Chemistry, 280
Bethzaida Astorga, R. Pelis, T. Wunz, Jennifer Perry, J. Pritchard, S. Wright (2007)
Molecular basis for the differential sensitivity of OCT2 and OAT1 toward Hg2+The FASEB Journal, 21
D. Sengupta, P. Lum, Yurong Lai, E. Shubochkina, A. Bakken, G. Schneider, J. Unadkat (2002)
A single glycine mutation in the equilibrative nucleoside transporter gene, hENT1, alters nucleoside transport activity and sensitivity to nitrobenzylthioinosine.Biochemistry, 41 5
C. Hilgendorf, Gustav Ahlin, A. Seithel, P. Artursson, A. Ungell, J. Karlsson (2007)
Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell LinesDrug Metabolism and Disposition, 35
C. Galmarini, X. Thomas, F. Calvo, P. Rousselot, M. Rabilloud, Assia Jaffari, E. Cros, C. Dumontet (2002)
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemiaBritish Journal of Haematology, 117
P. Swaan, M. Stehouwer, J. Tukker (1995)
Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril.Biochimica et biophysica acta, 1236 1
Habib Hasannejad, M. Takeda, Kentaro Taki, H. Shin, E. Babu, P. Jutabha, Suparat Khamdang, M. Aleboyeh, Maristela Onozato, A. Tojo, A. Enomoto, N. Anzai, S. Narikawa, X. Huang, T. Niwa, H. Endou (2004)
Interactions of Human Organic Anion Transporters with DiureticsJournal of Pharmacology and Experimental Therapeutics, 308
R. Maréchal, J. Mackey, R. Lai, P. Demetter, M. Peeters, M. Polus, C. Cass, James Young, I. Salmon, J. Devière, J. Laethem (2009)
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic AdenocarcinomaClinical Cancer Research, 15
Fujun Li, L. Hong, Cheng-I Mau, R. Chan, T. Hendricks, C. Dvorak, C. Yee, Jason Harris, T. Alfredson (2006)
Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.Journal of pharmaceutical sciences, 95 6
J. Mackey, C. Galmarini, K. Graham, A. Joy, A. Delmer, L. Dabbagh, D. Glubrecht, L. Jewell, R. Lai, Thack Lang, J. Hanson, J. Young, H. Merle-Béral, J. Binet, C. Cass, C. Dumontet (2005)
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.Blood, 105 2
S. Lacy, M. Hitchcock, William Lee, P. Tellier, K. Cundy (1998)
Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.Toxicological sciences : an official journal of the Society of Toxicology, 44 2
Yasuna Kobayashi, N. Ohshiro, Ryoko Sakai, M. Ohbayashi, N. Kohyama, Toshinori Yamamoto (2005)
Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])Journal of Pharmacy and Pharmacology, 57
B. Feng, Y. Shu, K. Giacomini (2002)
Role of aromatic transmembrane residues of the organic anion transporter, rOAT3, in substrate recognition.Biochemistry, 41 28
S. Baldwin, P. Beal, S. Yao, A. King, C. Cass, J. Young (2004)
The equilibrative nucleoside transporter family, SLC29Pflügers Archiv, 447
M. Ritzel, S. Yao, A. Ng, J. Mackey, C. Cass, J. Young (1998)
Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.Molecular membrane biology, 15 4
R. Sata, H. Ohtani, M. Tsujimoto, H. Murakami, N. Koyabu, Takanori Nakamura, T. Uchiumi, M. Kuwano, H. Nagata, K. Tsukimori, H. Nakano, Y. Sawada (2005)
Functional Analysis of Organic Cation Transporter 3 Expressed in Human PlacentaJournal of Pharmacology and Experimental Therapeutics, 315
V. Moore, W. Irwin, P. Timmins, S. Chong, S. Dando, R. Morrison (2000)
A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterisation.International journal of pharmaceutics, 210 1-2
C. Galmarini, J. Mackey, C. Dumontet (2001)
Nucleoside analogues: mechanisms of drug resistance and reversal strategiesLeukemia, 15
H. Shen, D. Smith, T. Yang, Y. Huang, J. Schnermann, F. Brosius (1999)
Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney.The American journal of physiology, 276 5
G. Ciarimboli, T. Ludwig, D. Lang, H. Pavenstädt, H. Koepsell, H. Piechota, J. Haier, U. Jaehde, J. Zisowsky, E. Schlatter (2005)
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2.The American journal of pathology, 167 6
Sweet (2001)
Ventricular choline transport: A role for organic cation transporter 2 expressed in choroid plexusJ Biol Chem, 276
I. Tamai, R. Ohashi, J. Nezu, Y. Sai, D. Kobayashi, A. Oku, M. Shimane, A. Tsuji (2000)
Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice*The Journal of Biological Chemistry, 275
K. Engel, Mingyan Zhou, Joanne Wang (2004)
Identification and Characterization of a Novel Monoamine Transporter in the Human Brain*Journal of Biological Chemistry, 279
Lacy (1998)
Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeysToxicol Sci, 44
C. Endres, D. Sengupta, J. Unadkat (2004)
Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.The Biochemical journal, 380 Pt 1
J. Young, S. Yao, L. Sun, C. Cass, S. Baldwin (2008)
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteinsXenobiotica, 38
Jing Zhang, Frank Visser, K. King, S. Baldwin, J. Young, C. Cass (2007)
The role of nucleoside transporters in cancer chemotherapy with nucleoside drugsCancer and Metastasis Reviews, 26
Yurong Lai, A. Bakken, J. Unadkat (2002)
Simultaneous Expression of hCNT1-CFP and hENT1-YFP in Madin-Darby Canine Kidney CellsThe Journal of Biological Chemistry, 277
L. Mangravite, Guangqing Xiao, K. Giacomini (2003)
Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells.American journal of physiology. Renal physiology, 284 5
Ulrich Karbach, Jörn Kricke, Friederike Meyer-Wentrup, V. Gorboulev, C. Volk, Dominique Loffing-Cueni, Brigitte Kaissling, Sebastian Bachmann, H. Koepsell (2000)
Localization of organic cation transporters OCT1 and OCT2 in rat kidney.American journal of physiology. Renal physiology, 279 4
Dmitry Gorbunov, V. Gorboulev, N. Shatskaya, T. Mueller, E. Bamberg, T. Friedrich, H. Koepsell (2008)
High-Affinity Cation Binding to Organic Cation Transporter 1 Induces Movement of Helix 11 and Blocks Transport after Mutations in a Modeled Interaction Domain between Two HelicesMolecular Pharmacology, 73
M. Tsuda, T. Terada, Megumi Irie, T. Katsura, Ayumu Niida, K. Tomita, N. Fujii, K. Inui (2006)
Transport Characteristics of a Novel Peptide Transporter 1 Substrate, Antihypotensive Drug Midodrine, and Its Amino Acid DerivativesJournal of Pharmacology and Experimental Therapeutics, 318
Aaron Yeung, Sujit Basu, Sharon Wu, Chun Chu, Curtis Okamoto, S. Hamm-Alvarez, H. Grafenstein, Wei-Chiang Shen, Kwang-Jin Kim, Michael Bolger, Ian Haworth, David Ann, Vincent Lee (1998)
Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1).Biochemical and biophysical research communications, 250 1
Takashi Yamamoto, Kenichi Kuniki, Y. Takekuma, T. Hirano, K. Iseki, M. Sugawara (2007)
Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.European journal of pharmacology, 557 1
C. Crawford, D. Patel, C. Naeve, J. Belt (1998)
Cloning of the Human Equilibrative, Nitrobenzylmercaptopurine Riboside (NBMPR)-insensitive Nucleoside Transporter ei by Functional Expression in a Transport-deficient Cell Line*The Journal of Biological Chemistry, 273
M. Vickers, Jing Zhang, Frank Visser, Tracey Tackaberry, M. Robins, L. Nielsen, I. Nowak, S. Baldwin, J. Young, C. Cass (2004)
NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS
K. Lips, C. Volk, B. Schmitt, U. Pfeil, P. Arndt, D. Miska, L. Ermert, W. Kummer, H. Koepsell (2005)
Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium.American journal of respiratory cell and molecular biology, 33 1
A. Busch, U. Karbach, D. Miska, V. Gorboulev, A. Akhoundova, C. Volk, P. Arndt, J. Ulzheimer, M. Sonders, Carmen Baumann, S. Waldegger, Florian Lang, H. Koepsell (1998)
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.Molecular pharmacology, 54 2
V. Gorboulev, N. Shatskaya, C. Volk, H. Koepsell (2005)
Subtype-Specific Affinity for Corticosterone of Rat Organic Cation Transporters rOCT1 and rOCT2 Depends on Three Amino Acids within the Substrate Binding RegionMolecular Pharmacology, 67
Harunobu Tahara, Masayuki Shono, H. Kusuhara, H. Kinoshita, E. Fuse, A. Takadate, M. Otagiri, Y. Sugiyama (2005)
Molecular Cloning and Functional Analyses of OAT1 and OAT3 from Cynomolgus Monkey KidneyPharmaceutical Research, 22
T. Terada, Megumi Irie, M. Okuda, K. Inui (2004)
Genetic variant Arg57His in human H+/peptide cotransporter 2 causes a complete loss of transport function.Biochemical and biophysical research communications, 316 2
David Smith, A. Pavlova, U. Berger, M. Hediger, Tianxin Yang, Yuning Huang, J. Schnermann (1998)
Tubular Localization and Tissue Distribution of Peptide Transporters in Rat KidneyPharmaceutical Research, 15
S. Patil, L. Ngo, P. Glue, J. Unadkat (1998)
Intestinal Absorption of Ribavirin Is Preferentially Mediated by the Na+-Nucleoside Purine (Nl) TransporterPharmaceutical Research, 15
U. Berger, M. Hediger (1999)
Distribution of peptide transporter PEPT2 mRNA in the rat nervous systemAnatomy and Embryology, 199
Norma Jung, C. Lehmann, A. Rubbert, M. Knispel, P. Hartmann, J. Lunzen, H. Stellbrink, G. Faetkenheuer, D. Taubert (2008)
Relevance of the Organic Cation Transporters 1 and 2 for Antiretroviral Drug Therapy in Human Immunodeficiency Virus InfectionDrug Metabolism and Disposition, 36
M. Pastor-Anglada, P. Cano‐Soldado, E. Errasti-Murugarren, F. Casado (2008)
SLC28 genes and concentrative nucleoside transporter (CNT) proteins.Xenobiotica; the fate of foreign compounds in biological systems, 38 7-8
Y. Urakami, Maiko Akazawa, H. Saito, M. Okuda, K. Inui (2002)
cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney.Journal of the American Society of Nephrology : JASN, 13 7
J. Ward, G. Leung, Shuy-Vang Toan, C. Tse (2003)
Functional analysis of site-directed glycosylation mutants of the human equilibrative nucleoside transporter-2.Archives of biochemistry and biophysics, 411 1
M. Sundaram, S. Yao, A. Ng, C. Cass, S. Baldwin, J. Young (2001)
Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins.Biochemistry, 40 27
M. Hosoyamada, T. Sekine, Y. Kanai, H. Endou (1999)
Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney.American journal of physiology. Renal physiology, 276 1
E. Babu, M. Takeda, S. Narikawa, Yukari Kobayashi, A. Enomoto, A. Tojo, S. Cha, T. Sekine, D. Sakthisekaran, H. Endou (2002)
Role of human organic anion transporter 4 in the transport of ochratoxin A.Biochimica et biophysica acta, 1590 1-3
C. Popp, V. Gorboulev, T. Müller, Dmitry Gorbunov, N. Shatskaya, H. Koepsell (2005)
Amino Acids Critical for Substrate Affinity of Rat Organic Cation Transporter 1 Line the Substrate Binding Region in a Model Derived from the Tertiary Structure of Lactose PermeaseMolecular Pharmacology, 67
A. Rizwan, G. Burckhardt (2007)
Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological RolesPharmaceutical Research, 24
M. Sugawara, Wei-qun Huang, Y. Fei, F. Leibach, V. Ganapathy, M. Ganapathy (2000)
Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.Journal of pharmaceutical sciences, 89 6
S. Eraly, K. Bush, R. Sampogna, V. Bhatnagar, S. Nigam (2004)
The molecular pharmacology of organic anion transporters: from DNA to FDA?Molecular pharmacology, 65 3
Kevin Robillard, Derek Bone, Jamie Park, J. Hammond (2008)
Characterization of mENT1Δ11, a Novel Alternative Splice Variant of the Mouse Equilibrative Nucleoside Transporter 1Molecular Pharmacology, 74
Melissa Slugoski, A. Ng, S. Yao, Kyla Smith, Colin Lin, Jing Zhang, E. Karpinski, C. Cass, S. Baldwin, J. Young (2008)
A Proton-mediated Conformational Shift Identifies a Mobile Pore-lining Cysteine Residue (Cys-561) in Human Concentrative Nucleoside Transporter 3*Journal of Biological Chemistry, 283
E. Errasti-Murugarren, M. Molina-Arcas, F. Casado, M. Pastor-Anglada (2009)
A splice variant of the SLC28A3 gene encodes a novel human concentrative nucleoside transporter‐3 (hCNT3) protein localized in the endoplasmic reticulumThe FASEB Journal, 23
Enomoto (2002)
Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitorsJ Pharmacol Exp Ther, 301
Melissa Slugoski, Kyla Smith, Ras Mulinta, A. Ng, S. Yao, E. Morrison, Queenie Lee, Jing Zhang, E. Karpinski, C. Cass, S. Baldwin, J. Young (2008)
A Conformationally Mobile Cysteine Residue (Cys-561) Modulates Na+ and H+ Activation of Human CNT3*Journal of Biological Chemistry, 283
A. Yamashita, Satinder Singh, T. Kawate, Yan Jin, E. Gouaux (2005)
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transportersNature, 437
Gustav Ahlin, J. Karlsson, Jenny Pedersen, L. Gustavsson, R. Larsson, P. Matsson, U. Norinder, Christel Bergström, P. Artursson (2008)
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.Journal of medicinal chemistry, 51 19
Jing Zhang, Frank Visser, M. Vickers, Thack Lang, M. Robins, L. Nielsen, I. Nowak, S. Baldwin, J. Young, C. Cass (2003)
Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae.Molecular pharmacology, 64 6
S. Theis, I. Knütter, B. Hartrodt, M. Brandsch, G. Kottra, K. Neubert, H. Daniel (2002)
Synthesis and Characterization of High Affinity Inhibitors of the H+/Peptide Transporter PEPT2*The Journal of Biological Chemistry, 277
E. Babu, M. Takeda, S. Narikawa, Yasuna Kobayashi, Toshinori Yamamoto, S. Cha, T. Sekine, D. Sakthisekaran, H. Endou (2002)
Human organic anion transporters mediate the transport of tetracycline.Japanese journal of pharmacology, 88 1
Frank Visser, Jing Zhang, R. Raborn, S. Baldwin, James Young, C. Cass (2005)
Residue 33 of Human Equilibrative Nucleoside Transporter 2 Is a Functionally Important Component of Both the Dipyridamole and Nucleoside Binding SitesMolecular Pharmacology, 67
Xing-Zhen Chen, Angela Steel, M. Hediger (2000)
Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1.Biochemical and biophysical research communications, 272 3
Shauna Loewen, A. Ng, S. Yao, C. Cass, S. Baldwin, J. Young (1999)
Identification of Amino Acid Residues Responsible for the Pyrimidine and Purine Nucleoside Specificities of Human Concentrative Na+ Nucleoside Cotransporters hCNT1 and hCNT2*The Journal of Biological Chemistry, 274
Chutima Srimaroeng, J. Perry, J. Pritchard (2008)
Physiology, structure, and regulation of the cloned organic anion transportersXenobiotica, 38
Lei Zhang, Wenche Gorset, M. Dresser, K. Giacomini (1999)
The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.The Journal of pharmacology and experimental therapeutics, 288 3
S. Yao, A. Ng, M. Sundaram, C. Cass, S. Baldwin, J. Young (2001)
Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes.Molecular membrane biology, 18 2
H. Koepsell, K. Lips, C. Volk (2007)
Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical ImplicationsPharmaceutical Research, 24
Eun-Woo Lee, Yurong Lai, Huixia Zhang, J. Unadkat (2006)
Identification of the Mitochondrial Targeting Signal of the Human Equilibrative Nucleoside Transporter 1 (hENT1)Journal of Biological Chemistry, 281
N. Kimura, M. Okuda, K. Inui (2005)
Metformin Transport by Renal Basolateral Organic Cation Transporter hOCT2Pharmaceutical Research, 22
C. Endres, J. Unadkat (2005)
Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S6-(4-Nitrobenzyl)-mercaptopurine Riboside, and DipyridamoleMolecular Pharmacology, 67
K. King, V. Damaraju, M. Vickers, S. Yao, Thach Lang, Tracey Tackaberry, D. Mowles, A. Ng, J. Young, C. Cass (2006)
A Comparison of the Transportability, and Its Role in Cytotoxicity, of Clofarabine, Cladribine, and Fludarabine by Recombinant Human Nucleoside Transporters Produced in Three Model Expression SystemsMolecular Pharmacology, 69
K. Umehara, T. Iwatsubo, K. Noguchi, H. Kamimura (2007)
Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidatesXenobiotica, 37
D. Meredith (2004)
Site-directed Mutation of Arginine 282 to Glutamate Uncouples the Movement of Peptides and Protons by the Rabbit Proton-peptide Cotransporter PepT1*Journal of Biological Chemistry, 279
Gerard Minuesa, C. Volk, M. Molina-Arcas, V. Gorboulev, I. Erkizia, P. Arndt, B. Clotet, M. Pastor-Anglada, H. Koepsell, J. Martinez-Picado (2009)
Transport of Lamivudine [(-)-β-l-2′,3′-Dideoxy-3′-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3Journal of Pharmacology and Experimental Therapeutics, 329
B. Burckhardt, G. Burckhardt (2003)
Transport of organic anions across the basolateral membrane of proximal tubule cells.Reviews of physiology, biochemistry and pharmacology, 146
M. Dresser, Guangqing Xiao, M. Leabman, A. Gray, K. Giacomini (2002)
Interactions of n-Tetraalkylammonium Compounds and Biguanides with a Human Renal Organic Cation Transporter (hOCT2)Pharmaceutical Research, 19
M. Alebouyeh, M. Takeda, Maristela Onozato, A. Tojo, Rie Noshiro, Habib Hasannejad, J. Inatomi, S. Narikawa, X. Huang, Suparat Khamdang, N. Anzai, H. Endou (2003)
Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites.Journal of pharmacological sciences, 93 4
G. Ciarimboli (2008)
Organic cation transportersXenobiotica, 38
B. Feng, M. Dresser, Y. Shu, S. Johns, K. Giacomini (2001)
Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3.Biochemistry, 40 18
David Truong, G. Kaler, Akash Khandelwal, P. Swaan, S. Nigam (2008)
Multi-level Analysis of Organic Anion Transporters 1, 3, and 6 Reveals Major Differences in Structural Determinants of Antiviral Discrimination*Journal of Biological Chemistry, 283
Suparat Khamdang, M. Takeda, E. Babu, Rie Noshiro, Maristela Onozato, A. Tojo, A. Enomoto, X. Huang, S. Narikawa, N. Anzai, P. Piyachaturawat, H. Endou (2003)
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.European journal of pharmacology, 465 1-2
D. Santini, G. Perrone, B. Vincenzi, R. Lai, C. Cass, R. Alloni, C. Rabitti, A. Antinori, F. Vecchio, S. Morini, P. Magistrelli, Roberto Coppola, J. Mackey, G. Tonini (2007)
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 19 4
M. Molina-Arcas, G. Moreno-Bueno, P. Cano‐Soldado, H. Hernández-Vargas, F. Casado, J. Palacios, M. Pastor-Anglada (2006)
Human equilibrative nucleoside transporter-1 (hENT1) is required for the transcriptomic response of the nucleoside-derived drug 5'-DFUR in breast cancer MCF7 cells.Biochemical pharmacology, 72 12
V. Gorboulev, C. Volk, P. Arndt, A. Akhoundova, H. Koepsell (1999)
Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.Molecular pharmacology, 56 6
Yurong Lai, C. Tse, J. Unadkat (2004)
Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs*Journal of Biological Chemistry, 279
Wen Xu, Kunihiko Tanaka, A. Sun, G. You (2006)
Functional Role of the C Terminus of Human Organic Anion Transporter hOAT1*Journal of Biological Chemistry, 281
Xiaohong Zhang, Nikhil Shirahatti, D. Mahadevan, S. Wright (2005)
A Conserved Glutamate Residue in Transmembrane Helix 10 Influences Substrate Specificity of Rabbit OCT2 (SLC22A2)*Journal of Biological Chemistry, 280
Nelson Osses, Nelson Osses, Jeremy Pearson, D. Yudilevich, D. Yudilevich, Simon Jarvis (1996)
Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter.The Biochemical journal, 317 ( Pt 3)
Frank Visser, S. Baldwin, R. Isaac, J. Young, C. Cass (2005)
Identification and Mutational Analysis of Amino Acid Residues Involved in Dipyridamole Interactions with Human and Caenorhabditis elegans Equilibrative Nucleoside Transporters*Journal of Biological Chemistry, 280
D. Yernool, O. Boudker, Yan-Ping Jin, E. Gouaux (2004)
Structure of a glutamate transporter homologue from Pyrococcus horikoshiiNature, 431
A. Mulato, Edmund Ho, T. Cihlář (2000)
Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.The Journal of pharmacology and experimental therapeutics, 295 1
Kaler (2007)
Structural variation governs substrate specificity for organic anion transporter (OAT) homologsPotential remote sensing by OAT family members., 282
R. Moaddel, S. Ravichandran, F. Bighi, R. Yamaguchi, I. Wainer (2007)
Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1)British Journal of Pharmacology, 151
H. Koepsell, H. Endou (2004)
The SLC22 drug transporter familyPflügers Archiv, 447
M. Lostao, João Mata, I. Larráyoz, Simone Inzillo, F. Casado, M. Pastor-Anglada (2000)
Electrogenic uptake of nucleosides and nucleoside‐derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytesFEBS Letters, 481
Tong Zhu, Xing-Zhen Chen, A. Steel, M. Hediger, David Smith (2000)
Differential Recognition of ACE Inhibitors in Xenopus Laevis Oocytes Expressing Rat PEPT1 and PEPT2Pharmaceutical Research, 17
Yurong Lai, Eun-Woo Lee, C. Ton, S. Vijay, Huixia Zhang, J. Unadkat (2005)
Conserved residues F316 and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitivity and membrane expression, respectively.American journal of physiology. Cell physiology, 288 1
Juan Wang, K. Giacomini (1997)
Molecular Determinants of Substrate Selectivity in Na+-dependent Nucleoside Transporters*The Journal of Biological Chemistry, 272
T. Terada, H. Saito, Kyoko Sawada, Y. Hashimoto, K. Inui (2004)
N-terminal Halves of Rat H+/Peptide Transporters Are Responsible for Their Substrate RecognitionPharmaceutical Research, 17
L. Mangravite, K. Giacomini (2003)
Sorting of Rat SPNT in Renal Epithelium Is Independent of N-GlycosylationPharmaceutical Research, 20
M. Takeda, Suparat Khamdang, S. Narikawa, Hiroaki Kimura, Yasuna Kobayashi, Toshinori Yamamoto, S. Cha, T. Sekine, H. Endou (2002)
Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.The Journal of pharmacology and experimental therapeutics, 300 3
E. Errasti-Murugarren, P. Cano‐Soldado, M. Pastor-Anglada, F. Casado (2008)
Functional Characterization of a Nucleoside-Derived Drug Transporter Variant (hCNT3C602R) Showing Altered Sodium-Binding CapacityMolecular Pharmacology, 73
P. Cano‐Soldado, Lorráyoz Im, M. Molina-Arcas, F. Casado, J. Martinez-Picado, M. Lostao, M. Pastor-Anglada (2004)
Interaction of Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with the Concentrative Nucleoside Transporter-1 (Slc28A1)Antiviral Therapy, 9
K. Covitz, Gordon Amidon, Wolfgang Sadée (1998)
Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.Biochemistry, 37 43
Mei Hong, Fanfan Zhou, G. You (2004)
Critical Amino Acid Residues in Transmembrane Domain 1 of the Human Organic Anion Transporter hOAT1*Journal of Biological Chemistry, 279
Johanna Müller, K. Lips, L. Metzner, R. Neubert, H. Koepsell, M. Brandsch (2005)
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).Biochemical pharmacology, 70 12
Jing Zhang, Kyla Smith, Tracey Tackaberry, Frank Visser, M. Robins, L. Nielsen, I. Nowak, E. Karpinski, S. Baldwin, J. Young, C. Cass (2005)
Uridine Binding and Transportability Determinants of Human Concentrative Nucleoside TransportersMolecular Pharmacology, 68
R. Pelis, Xiaohong Zhang, Yodying Dangprapai, S. Wright (2006)
Cysteine Accessibility in the Hydrophilic Cleft of Human Organic Cation Transporter 2*Journal of Biological Chemistry, 281
Kyla Smith, A. Ng, S. Yao, Kathy Labedz, E. Knaus, L. Wiebe, C. Cass, S. Baldwin, Xing-Zhen Chen, E. Karpinski, J. Young (2004)
Electrophysiological characterization of a recombinant human Na+‐coupled nucleoside transporter (hCNT1) produced in Xenopus oocytesThe Journal of Physiology, 558
D. Bednarczyk, S. Ekins, J. Wikel, S. Wright (2003)
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.Molecular pharmacology, 63 3
Xueqin Song, P. Lorenzi, C. Landowski, B. Vig, J. Hilfinger, G. Amidon (2005)
Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.Molecular pharmaceutics, 2 2
J. Links, A. Kulkarni, D. Davies, V. Lee, I. Haworth (2007)
Cysteine scanning of transmembrane domain three of the human dipeptide transporter: Implications for substrate transportJournal of Drug Targeting, 15
A. Yonezawa, S. Masuda, Sachiko Yokoo, T. Katsura, K. Inui (2006)
Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family)Journal of Pharmacology and Experimental Therapeutics, 319
E. Errasti-Murugarren, M. Pastor-Anglada, F. Casado (2007)
Role of CNT3 in the transepithelial flux of nucleosides and nucleoside‐derived drugsThe Journal of Physiology, 582
R. Yarchoan, H. Mitsuya, C. Myers, S. Broder (1989)
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides.The New England journal of medicine, 321 11
O. Zolk, T. Solbach, J. König, M. Fromm (2009)
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)Naunyn-Schmiedeberg's Archives of Pharmacology, 379
Melissa Slugoski, A. Ng, S. Yao, Colin Lin, Ras Mulinta, C. Cass, S. Baldwin, J. Young (2009)
Substituted Cysteine Accessibility Method Analysis of Human Concentrative Nucleoside Transporter hCNT3 Reveals a Novel Discontinuous Region of Functional Importance within the CNT Family Motif (G/A)XKX3NEFVA(Y/M/F)*The Journal of Biological Chemistry, 284
Frank Visser, M. Vickers, A. Ng, S. Baldwin, J. Young, C. Cass (2002)
Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole*The Journal of Biological Chemistry, 277
Kyla Smith, Melissa Slugoski, C. Cass, S. Baldwin, E. Karpinski, J. Young (2007)
Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3Molecular Membrane Biology, 24
I. Knütter, S. Theis, B. Hartrodt, I. Born, M. Brandsch, H. Daniel, K. Neubert (2001)
A novel inhibitor of the mammalian peptide transporter PEPT1.Biochemistry, 40 14
Huankai Hu, C. Endres, Cheng Chang, N. Umapathy, Eun-Woo Lee, Y. Fei, S. Itagaki, P. Swaan, V. Ganapathy, J. Unadkat (2006)
Electrophysiological Characterization and Modeling of the Structure Activity Relationship of the Human Concentrative Nucleoside Transporter 3 (hCNT3)Molecular Pharmacology, 69
I. Larráyoz, F. Casado, M. Pastor-Anglada, M. Lostao (2004)
Electrophysiological Characterization of the Human Na+/Nucleoside Cotransporter 1 (hCNT1) and Role of Adenosine on hCNT1 Function*Journal of Biological Chemistry, 279
J. Mackey, S. Yao, Kyla Smith, E. Karpinski, S. Baldwin, C. Cass, J. Young (1999)
Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.Journal of the National Cancer Institute, 91 21
M. Vickers, R. Mani, M. Sundaram, D. Hogue, J. Young, S. Baldwin, C. Cass (1999)
Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).The Biochemical journal, 339 ( Pt 1)
J. Spratlin, R. Sangha, D. Glubrecht, L. Dabbagh, J. Young, C. Dumontet, C. Cass, R. Lai, J. Mackey (2004)
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas AdenocarcinomaClinical Cancer Research, 10
Lei Zhang, Wenche Gorset, Carla Washington, Terrence Blaschke, D. Kroetz, K. Giacomini (2000)
Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.Drug metabolism and disposition: the biological fate of chemicals, 28 3
(1994)
Membrane transport of 2-chloro-20-deoxyadenosine and 2-chloro-20arabinofluoro-20deoxyadenosine is required for cytotoxicity
Melissa Slugoski, Kyla Smith, A. Ng, S. Yao, E. Karpinski, C. Cass, S. Baldwin, J. Young (2009)
Conserved Glutamate Residues Glu-343 and Glu-519 Provide Mechanistic Insights into Cation/Nucleoside Cotransport by Human Concentrative Nucleoside Transporter hCNT3*The Journal of Biological Chemistry, 284
V. Gorboulev, J. Ulzheimer, A. Akhoundova, I. Ulzheimer-Teuber, Ulrich Karbach, Sven Quester, Carmen Baumann, Florian Lang, Andreas Busch, H. Koepsell (1997)
Cloning and characterization of two human polyspecific organic cation transporters.DNA and cell biology, 16 7
Nucleoside transporters (NT) are integral membrane proteins implicated in the salvage of natural nucleobases and nucleosides for nucleic acid synthesis. These proteins also play a crucial role as carriers of nucleoside analogs used in anticancer and antiviral therapies. In fact, differential expression patterns of NT subtypes among tissues and individuals as well as the existence of genetic variants affect nucleoside‐derived drug permeation, and consequently, their pharmacokinetic and cytotoxic properties. Thus, NT expression patterns may be effective predictive markers of therapeutic response. While the structures of NT proteins are yet to be solved, specific residues responsible for interaction with substrates and inhibitors have been identified, providing further insights into their structure‐function relationship. In addition to transporter structural features, several experimental approaches have been used to identify the structural requirements of nucleosides for interaction with Concentrative Nucleoside Transporters and Equilibrative Nucleoside Transporters (SLC28 and SLC29 gene families, respectively). Pharmacophore models proposed for both protein families may prove suitable for optimizing drug design. Additional transporter proteins, including Organic Anion Transporters, Organic Cation Transporters (members of the SLC22 gene family), and Peptide Transporters (SLC15 gene family), have been implicated in the uptake of nucleoside‐derived drugs, particularly those currently used in antiviral therapies. In this review, we focus on the pharmacological profiles of these transporter proteins, summarizing the documented studies covering structure‐function and substrate structural requirement properties that determine drug‐carrier interaction and efficient substrate translocation across the plasma membrane of target cells. © 2011 Wiley Periodicals, Inc. Med Res Rev
Medicinal Research Reviews – Wiley
Published: Jan 1, 2012
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.